{
    "2020-04-30": [
        [
            {
                "time": "",
                "original_text": "【华泰医药代雯团队】华熙生物（688363，买入）年报点评：见龙在田，蓄势而上",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "年报",
                        "买入",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "下周218亿市值限售股解禁，环比减少47.93% 解禁",
                "features": {
                    "keywords": [
                        "限售股",
                        "解禁",
                        "市值"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "新晋国货母婴个护品牌华熙生物润熙禾：以质造初心呵护母婴敏感肌肤",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "母婴",
                        "个护品牌",
                        "敏感肌肤"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "玻尿酸的中场战事",
                "features": {
                    "keywords": [
                        "玻尿酸",
                        "市场竞争"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "化妆品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国元医药】华熙生物19年报&20Q1点评：19年业绩快速增长，20Q1受疫情增速放缓",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "年报",
                        "疫情",
                        "业绩增长",
                        "增速放缓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "晨会聚焦200430重点关注永辉超市、华熙生物、凯撒旅游、凯利泰、汉钟精机、长电科技、广州酒家、美吉姆、新华保险、迈瑞医疗",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "晨会聚焦",
                        "重点关注"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国盛服饰】华熙生物丨点评：疫情短期影响整形外科产品销售，长期各赛道成长逻辑坚实",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "疫情",
                        "整形外科",
                        "成长逻辑"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【国信零售|财报点评】华熙生物：护肤品保持高增长，卡位优质赛道前景广阔",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "护肤品",
                        "高增长",
                        "优质赛道"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费品",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "QFII一季度青睐白马股，重仓银行医药电子",
                "features": {
                    "keywords": [
                        "QFII",
                        "白马股",
                        "重仓",
                        "银行",
                        "医药",
                        "电子"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "银行",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "QFII青睐白马股重仓银行医药电子",
                "features": {
                    "keywords": [
                        "QFII",
                        "白马股",
                        "重仓",
                        "银行",
                        "医药",
                        "电子"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "银行",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}